The melanoma growth stimulatory activity/growth regulated protein, CXCL1, is constitutively expressed at high levels during inflammation and progression of melanocytes into malignant melanoma. It has been previously shown that CXCL1 overexpression in melanoma cells is due to increased transcription as well as stability of the Furthermore, 3−aminobenzamide, an inhibitor of PARP-specific ADP-ribosylation, inhibits CXCL1 promoter activity and reduces levels of CXCL1 mRNA. The data point to the possibility that PARP may be a co-activator of CXCL1 transcription.
Introduction
The melanoma growth stimulatory activity/growth regulated protein (CXCL1) chemokine plays an important role in wound healing, inflammation and tumorigenesis (1) . The CXCL1 gene is not constitutively expressed in normal retinal pigment epithelial cells (RPE) but can be induced by cytokines such as interleukin-1 (IL-1) and tumor necrosis factor α (TNF α) and bacterial products such as lipopolysaccharide (LPS). In contrast, Hs294T malignant melanoma cells exhibit high, constitutive levels of CXCL1 mRNA. IL-1 treatment of Hs294T cells does not significantly increase the transcription of the gene, although it does appear to stabilize CXCL1 mRNA (2) .
Transcription of the CXCL1 gene is regulated through a 306 bp minimal promoter comprising four cis-acting elements which include the TATA box (-25 to -30 nt), a NF-κB binding site (-67 to -77 nt), an AT-rich HMGI(Y) binding element nested within the NF-κB site, an immediate upstream region, IUR, (-78 to --93 nt) and a GC-rich SP1 binding site (-117 to -128 nt) (3) . In RPE cells, IL-1 increases nuclear levels of NF-κB p65 (Rel A) and NF-κB p50 subunits (4) . This is due to the IL-1 induced activation of the I-κB kinases (IKK1/IKK2) and subsequent phosphorylation, ubiquitination and degradation of the IKK substrate, I-κB. In Hs294T cells, constitutively high nuclear levels of the p50 and p65/RelA proteins can be correlated with constitutive activity of IKK1/ IKK2 and enhanced degradation of the I-κB protein. (5, 6) . The NF-κB element therefore represents a crucial, inducible component of the putative CXCL1 enhanceosome.
The IUR is an approximately 20 bp sequence which is located immediately upstream of the NF-κB site in the CXCL1 promoter. Previously we demonstrated that by guest on http://www.jbc.org/ Downloaded from 5 this element is essential for basal as well as cytokine expression of the CXCL1 gene. In particular, point mutations within a putative TCGAT motif abolished basal and IL-1 induced transcription in reporter gene assays with RPE and Hs294T cells. Furthermore, in electrophoretic mobility shift assays (EMSA), these mutations blocked the ability of this element to compete with a constitutive, IUR-specific complex in RPE and Hs294T nuclear extracts (7) . UV-crosslinking and Southwestern blot analyses revealed that at least one protein having a relative molecular size of 115 kDa bound the IUR element in a sequence-specific (8) . In this study the 115 kDa IUR-specific protein has been purified by binding-site oligonucleotide affinity chromatography. Peptide sequence analysis identifies this protein as Poly (ADP-ribose) polymerase (PARP).
PARP is a 114-115 kDa nuclear DNA binding protein, which catalyses the transfer of long, branched ADP-ribose chains to either itself or different classes of target proteins involved in chromatin decondensation, DNA replication, DNA repair and gene expression (9,10) ADP-ribosylation by PARP affects such cellular processes as apoptosis, necrosis, cellular differentiation and malignant transformation (11) . PARP appears to have dual functions in the regulation of transcription. PARP-mediated ADPribosylation of the transcription factors TATA-binding protein (TBP), Yin-Yang (YY1), Sp1 (12) , NF-κB (13) , and p53 (14) and alters the sequence-specific DNA binding of these protein and is thought to cause a reversible silencing of transcription. On the other hand, PARP has been shown to enhance activator-dependent transcription in vitro (15) .
More recently, PARP has been shown to activate muscle-specific gene expression by interacting with sequences in the MCAT element of the cardiac troponin T promoter and by ADP-ribosylating the MCAT-specific Transcription Enhancer Factor 1 (TEF-1) (16) . In addition, PARP increases the on-rate binding of nuclear factors to the PAX-6 gene enhancer (17) . Furthermore, PARP has been shown to activate transcription of genes involved in cell proliferation in cooperation with the transcription factor, B-MYB (18) and potentiates the transcriptional activation by the human T-cell Leukemia virus type 1 Tax protein (19) .
In this study, the IUR element of the CXCL1 promoter has been further characterized. Evidence presented here indicates that the IUR is a positive cis-acting element and its activity is dependent on its contiguity with the adjacent NF-κB element A 115 kDa IUR-specific activity has been purified by binding site oligonucleotide affinity chromatography and identified as PARP. A specific PARP inhibitor, 3-aminobenzamide, inhibits CXCL1 promoter activity and decreases the endogenous levels of CXCL1 mRNA in a dose-dependent manner. We propose that PARP is a potential co-activator of CXCL1 gene transcription. 
Materials and Methods

Cell Lines and treatments
Hs294T melanoma cells are a continuous cell line established from a human melanoma metastatic to the lymph node. These cells were obtained from American Type Culture Collection (Rockville, MD). RPE cells are normal retinal pigment epithelial cells that were cultured by Dr. Glenn Jaffe from the North Carolina Organ Donor and Eye Bank within 24 h of death. RPE and Hs294T cells were cultured as previously described (7) . In one series of experiments, Hs294T cells were incubated at 37 °C in the absence of serum for 48 h, during which period, cells received the indicated doses of 3-aminobenzamide (Sigma-Aldrich, St. Louis, MO) at 24 h intervals.
Sequence of oligonucleotides
The wildtype IUR probe, 2xIUR, used in electrophoretic mobility shift assays and The upper case characters represent nucleotide replacements in the TCGAT motif, while the underscored characters outline the IUR element repeats.
Reporter and Expression vectors
The CXCL1 minimal promoter region (-306 to +45 nt) was inserted in the pGL2 Basic vector ( Promega) either in the correct orientation ( pWT.Luc) or in the opposite orientation (pREV.Luc) relative to the transcription start site. To separate the IUR element from the NF-κB site, pWT.Luc was modified to include an Nco I site between the two elements using the GeneEditor in vitro site-directed mutagenesis sytem confirmed by restriction analysis and automated plasmid sequencing.
Reagents :
Anti-PARP antibodies were from Santacruz Biotechnology, Santacruz, CA. The PARP enzyme was purchased from R & D Systems Minneapolis, MN.
Electrophoretic Mobility Shift Assays.
Nuclear extracts were prepared as described previously (7) . 
Southwestern and Western Blot Analysis
Nuclear extracts (25 µg) were heated at 90 °C for 3 minutes in 50 mM Tris.Cl (pH:6.8), 100 mM DTT, 2% SDS and 10% glycerol, resolved on 4% stacking/8% resolving SDSpolyacrylamide gel and electrophoretically transferred to nitrocellulose membranes (Biorad Laboratories). The membranes were rocked for 30 minutes in PBS, blocked for 4 h at RT with buffer A (20 mM Hepes-NaOH, 50 mM NaCl, 12.5 mg/ml skim milk powder, 2.5 mg/ml bovine serum albumin, 100 µg/ml native salmon sperm DNA) and incubated overnight at RT in up to 2 ml of Buffer A + 10 7 cpm (8-10 pmoles) of radiolabeled 2xIUR or 2xmIUR probes. Membranes were subjected to three washes of 15 minutes each at RT in a buffer containing 20 mM Hepes-NaOH, 50 mM NaCl, 1g/L skim milk powder 0.025% Nonidet P40, prior to drying and autoradiography.
For western analysis, membranes were probed with 800 µg/10 ml of anti-PARP rabbit polyclonal antibody (cat # : sc-7150) from SantaCruz Antibodies, Santa Cruz, CA using procedures recommended by the antibody manufacturer and the signal was visualized by enhanced chemiluminescence (ECL) assay (Amersham Pharmacia Biotech)
according to the manufacturer's recommendations.
Northern Analysis :
Total RNA from Hs294T cells treated over a 48 h period with various doses of 3-aminobenzamide was isolated using the Ultraspec RNA isolation system ( Biotecx Laboratories, Houston, TX) according to the manufacturer's protocol. 20 µg/lane of purified RNA was used in northern analysis which was performed exactly as described previously (2) . After probing for levels of CXCL1 mRNA, blots were stripped by boiling for 10 minutes in water and re-probed with radiolabeled, cyclophilin cDNA. Bands corresponding to the CXCL1 and cyclophilin were analysed by phosphorimager using 
Transient Transfection and Reporter Activity assay :
Hs294T were plated in 60-mm dishes at a density of 2 X 10 5 . The following day, cells at nearly 70% confluency were transfected using the Lipofectamine/Plus method (Life Technologies, Rockville, MD) with 1 µg of the appropriate reporter construct containing either the wild type CXCL1 promoter (WT) or promoters containing insertions between the IUR and NF-κB elements or nucleotide replacements within the TCGAT motif of 12 the IUR element (mIUR.Luc). In addition, all samples received 1µg of pRSV-β-gal.
Cells were harvested 48 h after transfection and luciferase activity was measured using the luciferase assay system (Promega) and Monolight 2010 Luminometer (Analytical Luminiscence Laboratory, San Diego, CA
In transfection experiments where 3-Aminobenzamide was used, cells were first transfected with 1 µg of pRSV-β-gal reporter as well as reporter constructs driven by either the wild type (CXCL1.Luc) or the mutant CXCL1 (mIUR.Luc) promoters. Six hours after transfection, the medium was replaced by medium containing either DMSO or
Purification of the 115 kDa IUR-specific protein :
Binding site oligonucleotide affinity chromatography was performed using a modified protocol of Kadonaga et al.(20) . Briefly, multimers of the IUR were cross-linked to cyanogen bromide-activated agarose to generate the IUR-agarose column. Similarly, a control column containing mIUR multimers (mIUR-agarose) was made. Cells equivalent to 60 L HeLa suspension culture was obtained from National Cell Culture Center, Minneapolis, MN. Approximately 2.5 g of nuclear extract was prepared from these cells.
First, non-specific DNA binding proteins were competed with poly dI:dC at a protein :
DNA ratio of 30 : 1, incubated at room temperature for 6 h and eliminated by high speed centrifugation. Unbound proteins in the supernatant were subjected to binding site oligonucleotide chromatography which involved two passages through a 3ml settled bedvolume of the mutant IUR-agarose column, an overnight incubation with a 3 ml bedvolume of IUR-agarose resin, followed by two passes through the same column. After 5
washes of 3ml each in a 50 mM NaCl containing buffer, fractions were eluted from the IUR-agarose column by a step-gradient of buffers containing 0.2 to 1.0 M NaCl. In EMSA and Southwestern assays, the 400 mM NaCl fraction consistently tested positive for an activity with a relative molecular size of 115 kDa that specifically bound the 2xIUR probe. SDS-PAGE and silver staining revealed selective enrichment of the 115 kDa protein.
In order to further purify the 115 kDa protein, the 400 mM NaCl fraction was pooled, dialyzed against water, lyophilized and reconstituted in the 1x SDS-PAGE loading dye. The sample was then subjected to continuous-elution SDS-PAGE on a 7%
polyacrylamide gel using a Model 491 Prep Cell (Bio-Rad Laboratories, Hercules, CA). Figure 1A indicate that transcription from the CXCL1 promoter is inhibited by nearly 90% when the entire promoter is oriented in a direction opposite to the transcription start site (Rev). Furthermore, a 75% inhibition in promoter activity is observed when the T 1 C 2 G 3 A 4 T 5 motif in the IUR element is replaced by CXCL1 promoter activity is due to a change in the helical phase between the two elements. Together, the data suggest that the IUR is a positive cis acting element and that the transcriptional activity of the CXCL1 promoter is strictly dependent on the distance of the IUR element relative to the NF-κB site.
Purification and identification of 115 kDa IUR binding protein :
We have previously demonstrated that the IUR element binds a 115 kDa protein in Southwestern blot assays (8) . In order to identify the 115 kDa protein, which binds the IUR, we purified the IUR specific factor by binding site oligonucleotide affinity chromatography. HeLa nuclear extract proved to be a convenient and abundant source for In order to further purify the 115 kDa protein, the 400 mM IUR-agarose fractions were pooled, dialyzed and lyophilized to dryness. The reconstituted 400 mM fraction was then electrophoresed through a preparative SDS-PAGE miniprep cell and 265 fractions of 1.0 ml each were collected. Electro-eluted fractions were analyzed by SDS-PAGE/silver-staining. Figure 2D shows results of such an experiment. The 115 kDa protein electro-elutes reproducibly in fractions 135-160 of the minprep cell. 
The DNA-affinity purified 115 kDa protein is PARP :
We tested the 400 mM fraction from the IUR agarose column by Western blot analysis ( Figure 3A) to determine whether or not the 115 kDa is the poly ADP ribose polymerase (PARP). Anti-PARP antibodies successfully detected a 115 kDa protein in the fraction thus confirming that the affinity purified 115 kDa protein is PARP.
Recombinant PARP binds the CXCL1 IUR element in a sequence-specific manner.
Results in Figure 2 demonstrate that the 115 kDa protein (PARP) emerged in the unbound fraction of the mutant-IUR agarose column and eluted in the 400 mM fraction bound to IUR agarose column. This strongly suggested that the PARP protein could discriminate between the mutant and wild-type IUR sequences. To verify this, we used purified, recombinant PARP in EMSA and compared PARP binding to 2xIUR and 2xmIUR probes ( Figure 3B ). The use of poly dIdC in the reaction mixture was found to be necessary since the recombinant protein was not a homogenous preparation.
Specificity to IUR was observed at relatively high concentrations of the non-specific competitor DNA. Three shifted complexes could be detected with the 2xIUR probe. Two complexes, which were specific to 2xIUR, did not bind the 2xmIUR probe. This result indicates that PARP can form a sequence-specific complex with the IUR element of CXCL1. We would like to point out that the complex generated by the purified recombinant protein appears to differ in mobility and intensity to the one obtained from crude nuclear extracts. Moreover, there are two IUR specific complexes generated with the recombinant protein as opposed to a single complex observed with crude nuclear extracts. The reasons for these discrepancies are unclear at this time. However, it is likely that the complex observed in crude nuclear extract could be a composite of more than one protein in addition to PARP. promoter. This rules out the possibility that 3-AB mediated inhibition of CXCL1 mRNA levels is due to abrogation of other trans-acting factors of the CXCL1 promoter.
3-aminobenzamide (3-AB) decreases levels of
Binding of PARP to the IUR element does not require ADP-ribosylation:
Since 3-AB treatment had a dramatic effect on endogenous CXCL1 mRNA levels as well as on the CXCL1 promoter activity in reporter assays, we considered the possibility that binding of PARP to the IUR element might involve the ADP-ribosylation activity of the factor. Hs294T cells were treated with 3-AB within a dose range of 1-5 mM. Cells were harvested after 48 h of 3-AB treatment and nuclear extracts were prepared. Figure 6 shows a representative EMSA experiment in which nuclear extracts from DMSO treated 
Discussion
The CXCL1 gene is expressed at a high constitutive level in several disorders including acute and chronic inflammation and malignant melanoma. Our earlier findings indicate that the CXCL1 gene is under the control of a 306 bp minimal promoter containing four cis acting elements, including a 20 bp region called the IUR, located immediately upstream to the NF-κB binding sequence (7) . In an effort to understand the mechanism by which the CXCL1 gene is regulated, we have further characterized the IUR element in the CXCL1 promoter and examined its role in CXCL1 gene regulation.
To examine whether the IUR has a positive or negative role in CXCL1 regulation, we first made mutations in the CXCL1 promoter which either altered the TCGAT motif or separated it from the adjacent NF-κB element. When tested in luciferase reporter assays, these mutations effected an almost 50% inhibition in CXCL1 promoter activity.
The data indicate that the IUR is a positive regulatory sequence in the CXCL1 promoter and that the contiguity of the IUR and NF-κB element is critical for optimal promoter activity.
In electrophoretic mobility shift assays, we previously identified constitutive binding to the IUR element and detected a 115 kDa protein which bound to the IUR element in southwestern blot analyses. Mutations which altered the TCGAT motif eliminated binding in both assays suggesting that these interactions were specific to the TCGAT motif of the IUR element (8) . Taken together with our current observations from reporter assays, the evidence points to the possibility that p115 is a positive transcriptional regulator of the CXCL1 gene.
In this study we have purified the 115 kDa protein binding to the IUR element using a two-step procedure involving binding site oligonucleotide affinity chromatography and electrophoretic separation through a Biorad mini-prep cell. Preincubation of the nuclear extract through a mutant-IUR-sepharose matrix eliminated nonspecific proteins and ensured that bound fractions eluting from the wild-type IURsepharose matrix represented proteins that selectively bound the wild-type but not the mutant IUR oligonucleotide.
Peptide sequence analysis has established the identity of the 115 kDa IUR- We examined the possibility that PARP-mediated ADP-ribosylation plays a role in the regulation of CXCL1 gene expression. We addressed this question by examining the effects of 3-Aminobenzamide, a specific inhibitor of PARP-mediated ADPribosylation, on (1) CXCL1 mRNA levels, (2) CXCL1 promoter activity and (3) specific binding to the IUR oligonucleotide probe. We show here that inhibition by 3AB reduces CXCL1 mRNA levels and blocks CXCL1 promoter activity up to 50 % over untreated controls in a dose dependent manner. The level of inhibition seen with 3AB appears to be similar to that observed when the TCGAT motif in the CXCL1 promoter is altered. In addition, the activity of the mutant-IUR promoter appears to be insensitive to 3-AB treatment indicating that 3AB effects target events associated with the TCGAT motif.
Inhibition of PARP-mediated ADP-ribosylation, however had no effect on the complex associated with the IUR probe in EMSA indicating that although ADP-ribosylation is by guest on 
